DE60206280D1 - Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia - Google Patents

Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia

Info

Publication number
DE60206280D1
DE60206280D1 DE60206280T DE60206280T DE60206280D1 DE 60206280 D1 DE60206280 D1 DE 60206280D1 DE 60206280 T DE60206280 T DE 60206280T DE 60206280 T DE60206280 T DE 60206280T DE 60206280 D1 DE60206280 D1 DE 60206280D1
Authority
DE
Germany
Prior art keywords
sarcopenia
ginkgo biloba
medicament
extracts
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60206280T
Other languages
English (en)
Other versions
DE60206280T2 (de
Inventor
Yves Christen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Application granted granted Critical
Publication of DE60206280D1 publication Critical patent/DE60206280D1/de
Publication of DE60206280T2 publication Critical patent/DE60206280T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60206280T 2001-07-17 2002-07-16 Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia Expired - Lifetime DE60206280T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0109506A FR2827518B1 (fr) 2001-07-17 2001-07-17 Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie
FR0109506 2001-07-17
PCT/FR2002/002519 WO2003007973A1 (fr) 2001-07-17 2002-07-16 Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie

Publications (2)

Publication Number Publication Date
DE60206280D1 true DE60206280D1 (de) 2006-02-02
DE60206280T2 DE60206280T2 (de) 2006-07-27

Family

ID=8865590

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60206280T Expired - Lifetime DE60206280T2 (de) 2001-07-17 2002-07-16 Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia

Country Status (18)

Country Link
US (2) US7138148B2 (de)
EP (1) EP1411961B1 (de)
JP (1) JP4510445B2 (de)
KR (1) KR100891393B1 (de)
CN (1) CN1272016C (de)
AT (1) ATE304861T1 (de)
AU (1) AU2002334001B2 (de)
CA (1) CA2453254C (de)
DE (1) DE60206280T2 (de)
DK (1) DK1411961T3 (de)
ES (1) ES2250726T3 (de)
FR (1) FR2827518B1 (de)
HK (1) HK1069327A1 (de)
HU (1) HUP0400928A3 (de)
NZ (1) NZ530367A (de)
PL (1) PL202567B1 (de)
RU (1) RU2298411C2 (de)
WO (1) WO2003007973A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842425B1 (fr) * 2002-07-16 2005-04-08 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour favoriser la masse musculaire au detriment de la masse graisseuse
US8058211B2 (en) * 2007-12-12 2011-11-15 Halliburton Energy Services, Inc. Corrosion inhibitor intensifier compositions and associated methods
KR20120125357A (ko) 2010-02-10 2012-11-14 노파르티스 아게 근육 성장을 위한 방법 및 화합물
JP6002503B2 (ja) 2011-08-18 2016-10-05 株式会社半導体エネルギー研究所 カルバゾール化合物
KR102051433B1 (ko) 2013-08-27 2020-01-08 (주)네오팜 근육 분화 촉진 및 근육 강화용 조성물 및 외용제
KR101771486B1 (ko) 2015-06-25 2017-08-25 서울대학교산학협력단 특정 다마란 계열의 성분이 증가된 인삼추출물의 제조방법 및 이를 이용한 근육감소증 관련 질환 치료용 조성물
KR102281263B1 (ko) 2019-03-12 2021-07-26 주식회사 비티씨 갈릭산, 에피카테킨(ec), 및 에피갈로카테킨(egc)의 함량이 증가된 카테킨 효소처리물 및 이의 제조방법
CN113840536A (zh) 2019-05-31 2021-12-24 雀巢产品有限公司 用于在动物中提供健康有益效果的基于mct的营养共混物
KR102229177B1 (ko) 2019-12-27 2021-03-18 부산대학교 산학협력단 로즈마리 추출물 및 대두 추출물을 유효성분으로 함유하는 근육 감소증 예방 또는 치료용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338995A1 (de) * 1983-10-27 1985-05-09 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe Bilobalid enthaltende arzneimittel
AU3582597A (en) * 1996-06-28 1998-01-21 Viva America Marketing, Inc. Nutritional supplement composition and use
FR2763592B1 (fr) * 1997-05-20 1999-07-16 Sod Conseils Rech Applic Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
JP3293524B2 (ja) * 1997-06-17 2002-06-17 有限会社薬研 イチョウ葉抽出エキス担持粉体複合物及びその製造方法
FR2771639B1 (fr) * 1997-12-03 2000-05-05 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a faciliter le sevrage d'individus dependants de la consommation d'une substance engendrant une dependance et/ou une addiction
US6030621A (en) * 1998-03-19 2000-02-29 De Long; Xie Ginkgo biloba composition, method to prepare the same and uses thereof
FR2782008B1 (fr) * 1998-08-07 2003-04-25 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique

Also Published As

Publication number Publication date
RU2298411C2 (ru) 2007-05-10
KR20040013150A (ko) 2004-02-11
PL367089A1 (en) 2005-02-21
KR100891393B1 (ko) 2009-04-02
DK1411961T3 (da) 2006-02-06
EP1411961A1 (de) 2004-04-28
ATE304861T1 (de) 2005-10-15
FR2827518B1 (fr) 2005-07-08
CN1272016C (zh) 2006-08-30
CA2453254A1 (fr) 2003-01-30
EP1411961B1 (de) 2005-09-21
WO2003007973A1 (fr) 2003-01-30
CA2453254C (fr) 2011-02-15
AU2002334001B2 (en) 2007-07-19
US20060121135A1 (en) 2006-06-08
JP2005512956A (ja) 2005-05-12
US7138148B2 (en) 2006-11-21
RU2004104463A (ru) 2005-06-10
US20040166180A1 (en) 2004-08-26
HUP0400928A3 (en) 2008-04-28
CN1533281A (zh) 2004-09-29
US7232580B2 (en) 2007-06-19
HK1069327A1 (en) 2005-05-20
DE60206280T2 (de) 2006-07-27
HUP0400928A1 (hu) 2004-07-28
ES2250726T3 (es) 2006-04-16
FR2827518A1 (fr) 2003-01-24
PL202567B1 (pl) 2009-07-31
NZ530367A (en) 2006-05-26
JP4510445B2 (ja) 2010-07-21

Similar Documents

Publication Publication Date Title
HK1069327A1 (en) Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
DE60135755D1 (de) Verbindungen und methoden zur behandlung von hautverletzungen
WO2004091540A3 (en) Methods of treating pain and compositions for use therefor
DE69921662D1 (de) Verwendung von gingko biloba extrakten zur herstellung eines arzneimittels zur behandlung der amyotrophen lateralsklerose
WO2005011572A3 (en) Combination of drugs for the treatment of neoplasms
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
DE59914712D1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE448788T1 (de) Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen
ATE410172T1 (de) Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes
DE69733169D1 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
DE69622704T2 (de) Pharmazeutische zusammensetzungen zur behandlung von alkoholsucht
ATE382347T1 (de) Pharmazeutische zusammensetzung zur verwendung bei der behandlung von malignen erkrankungen, umfassend eine kombination aus bisphosphonaten, einem cox-2 inhibitor und einem taxol
DE60335892D1 (de) Pharmazeutische zusammensetzung zur herstellung eines medikaments zur behandlung und/oder vorbeugung und/oder fettleibigkeit im zusammenhang steht
DE60331654D1 (de) Nicht-radioaktives Strontiummittel zur Behandlung von Krebs
UA67795C2 (uk) Склад для лікування опікових ран, який включає мірамістин
ATE466587T1 (de) Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe
DE69312297T2 (de) Verwendung von 2-[4-(-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphtoquinon zur behandlung von krebs
ATE450267T1 (de) Verwendung von ginkgo biloba extrakten zur förderung der muskelmasse zum nachteil der fettmasse
DE69516602T2 (de) Verwendung von Bifemelan zur Herstellung eines Arzneimittels zur Behandlung der Hyperkinesie
DE50002999D1 (de) Verwendung von extrakten aus ginkgo-biloba-blättern zur behandlung von schlafstörungen
DE59913720D1 (de) Verfahren zur Herstellung eines Extraktes aus Copalchirinde und Verwendung der Neoflavonoide zur Behandlung von Diabetes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: IPSEN PHARMA S.A.S., BOULOGNE-BILLANCOURT, FR